New Brunswick government reimburses Lucentis* for residents suffering from leading cause of age-related vision loss

Wet AMD patients now have access to first medication to improve vision and restore quality of life DORVAL, QC, Nov. 16 /CNW Telbec/ - New Brunswickers with wet age-related macular degeneration … [Read more...]

Avastin Treatment for Macular Degeneration

The off-label usage of Avastin (bevacizumab) has become widespread as a treatment for age related macular degeneration.  Developed as a treatment for cancer, the drug manufacturer, GenenTech has … [Read more...]

Avastin vs Lucentis: Two Drugs, One Treatment for Macular Degeneration

Avastin and Lucentis are two anti-VEGF drugs with almost the exact same molecular make-up and both have been used to treat wet macular degeneration.  The similarities in both Avastin and Lucentis has … [Read more...]